Observationmodel-written summary

Terminalia avicennioides, T. macroptera and T. laxiflora extracts inhibited 50% of DPPH at 0.04 to 0.6 mg/mL.

A claim from Comparative phytochemical profile and biological activity of three Terminalia species as alternative antimicrobial therapies · 2024

Observationobservedoriginal resultpositivemeasured

Claim · model-written summary

Terminalia avicennioides, T. macroptera and T. laxiflora extracts inhibited 50% of DPPH at 0.04 to 0.6 mg/mL.

Taxon
Terminalia avicennioides , Terminalia macroptera, and Terminalia laxifloraTerminalia avicennioidesTerminalia macropteraTerminalia laxiflorae2
Outcome
inhibition of DPPHe2
Value
50 %e2
Qualifier
concentrations ranging from 0.04 to 0.6 mg/mLe2

Not reportedMaterialGeneCompoundOrgan / stageInteractorInteractor roleSecond interactorSecond interactor roleTreatmentComparatorSettingDirection

Organisms pictured · Representative pictures of the matched species, not figures from the paper.

Terminalia macroptera
Terminalia macroptera · TaxonJi-Elle · CC BY-SA 4.0 · Wikimedia Commons ↗

Verbatim

e2

“Terminalia avicennioides , Terminalia macroptera, and Terminalia laxiflora extracts demonstrated 50 % inhibition of DPPH at concentrations ranging from 0.04 to 0.6 mg/mL”

✓ located verbatim in the source · abstract, characters 1757–1926

Title

Comparative phytochemical profile and biological activity of three Terminalia species as alternative antimicrobial therapies

Jotham Yhi-pênê N'do; Dramane Paré; Loyapin Bondé; et al. Heliyon 2024. doi:10.1016/j.heliyon.2024.e40159

Other claims from this paper (5)

Record rev-e05f2c9648ee2b226371846399f95971ab7cabcb1ba0bb5c0281530b9c9f2703 · schema claims-v0.9 · position 3 in the model’s answer